Response to New Strain of MPOX in the United States

State and federal health agencies in the United States are preparing to respond to a new strain of mpox with fewer resources compared to the last outbreak in 2022. The World Health Organization has declared a public health emergency of international concern over the new strain, known as clade 1b, which is more severe than the previous outbreak. Health officials are leaning on past lessons but face challenges due to the privatization of the mpox vaccine and limited resources.

Preparation for Severe Version of MPOX in the U.S.

The U.S. is preparing for a more severe version of mpox, known as clade 1, which has caused over 600 deaths in Africa. The government is expanding surveillance efforts, making testing more widely available, and ensuring vaccines are accessible for high-risk individuals.

Monkeypox Outbreak in Africa

The World Health Organization declared monkeypox a global public health emergency due to a recent outbreak in the Democratic Republic of Congo that has spread to neighboring countries in Africa. Two viral clades of monkeypox are causing concern, with one strain being more transmissible and severe than the other. Vaccines are available in the U.S. but not widely accessible in affected African regions.

MPOX Outbreak in the DRC and Beyond

More than 14,000 mpox cases reported in the DRC this year. WHO declared mpox a public health emergency of international concern. Cases rising dramatically in the DRC, with a new clade variant causing concerns. Africa CDC also declared mpox a public health emergency of continental security.

Monkeypox Outbreak and Awareness in the US

Scientists are concerned about the lack of vigilance among Americans regarding the uptick in Monkeypox cases, as the World Health Organization warns of another potential outbreak. A study showed a significant decrease in awareness and concern compared to two years ago. A deadlier strain of the virus has emerged in Africa, with warning signs of a possible outbreak.

Monkeypox Outbreak

Scientists warn of a potential Monkeypox outbreak as cases increase in the Democratic Republic of Congo. Americans are not as concerned about the disease as they were in 2022. A deadlier strain, clade 2, has emerged in Africa with a higher fatality rate. World Health Organization is monitoring the situation closely.

CDC Alert for Severe Mpox Strain in Africa

The CDC issued an alert for a more severe strain of mpox spreading in parts of Africa. The WHO is considering declaring a public health emergency. The virus causes fevers, headaches, muscle aches, and can be deadly. The latest strain, clade 1, is different and more severe. The vaccine is effective for both clade 1 and clade 2.

Deadlier Form of Monkeypox (Mpox) Spreading Beyond Congo

A deadlier form of monkeypox, now known as mpox, has spread beyond Congo, causing fevers, headaches, and skin boils. The WHO is considering declaring it a global public health emergency. Children are particularly affected by the new strain, with a higher death rate. Vaccine uptake is low, especially in African countries.

Bird Flu Outbreak in U.S. Dairy Cows

Bird flu outbreak in dairy cows in the United States raises concerns about spread to humans. Cases confirmed in multiple states, with infected herds and human exposure reported. Government takes measures to contain and prevent further spread.

Bird Flu Outbreak Among Poultry Workers in Colorado

Three poultry workers in northeast Colorado are suspected to have contracted bird flu, specifically H5N1, while working at a commercial egg layer operation. The risk to the public is low, but federal officials are considering deploying bird flu vaccine.

COVID-19 Vaccine Safety

COVID-19 vaccines are generally safe with very rare severe side effects. Social media spreading misinformation about deaths caused by vaccines is unfounded. Experts emphasize benefits of vaccination outweigh risks.

Health News Updates

Various health-related topics covered by Fox News including a baby's successful eye surgeries, increase in gender dysphoria and eating disorders among U.S. kids, progress on an experimental Alzheimer's drug, sunburn care tips, integration of medical cannabis for seniors, exercises to improve brain health in dementia patients, prevention of scarring from bug bites and poison ivy, investigation on mushroom-infused chocolate bars, and positive results on a COVID-flu combo vaccine.

Acquisition of H5N1 Bird Flu Vaccines by U.S. and Europe

Poultry farmers in the U.S. and Europe are taking steps to acquire or manufacture H5N1 bird flu vaccines to protect workers from the highly pathogenic avian influenza that is on the rise. The virus has spread to dairy cattle and poses a potential risk of mutation to spread easily in humans.

Donald Trump booed at Libertarian National Convention

Donald Trump was booed and heckled at the Libertarian National Convention for his handling of COVID-19 and vaccine creation, despite trying to appeal to libertarians for support in the upcoming election.

Bird Flu Infection Linked to Dairy Cows in the U.S.

A second person in the U.S. has been infected with bird flu linked to dairy cows, but the risk to the general public remains low. The individual had mild symptoms and has recovered. Monitoring is ongoing to prevent human-to-human transmission.

Australian doctor's successful treatment of terminal brain tumor

Australian doctor diagnosed with terminal brain tumor last year is cancer-free thanks to a first-of-its-kind treatment he helped develop. Treatment included immunotherapy, combination of drugs before and after surgery, vaccine tailored to tumor's characteristics, and radiotherapy.

Withdrawal of Oxford-AstraZeneca Coronavirus Vaccine

The Oxford-AstraZeneca coronavirus vaccine is being withdrawn worldwide due to a rare but dangerous side effect, despite AstraZeneca claiming it is for commercial reasons. The vaccine has been linked to blood clots and deaths, leading to its removal from use in many countries. AstraZeneca states that newer vaccines are available to address variants of the virus.

AstraZeneca COVID-19 Vaccine Withdrawal

AstraZeneca requests withdrawal of its COVID-19 vaccine from European authorization due to safety concerns and lower efficacy compared to other vaccines, leading to a shift towards mRNA vaccines globally.

Avian Influenza and Potential Pandemic

The article discusses the recent case of avian influenza in Texas and the potential for a pandemic. It compares the HPAI virus to the SARS-CoV-2 virus and highlights the differences in transmission and preparedness. It also emphasizes the importance of prevention measures and early detection.

WHO approves new cholera vaccine to address global surge in cases

WHO approves a new cholera vaccine to address global surge in cases and depleted vaccine stockpiles. The vaccine is cheaper, quicker to make, and has shown to be effective in preventing the disease.

Measles resurgence in the United States

In 2024, over 80% of measles cases in the U.S. involved unvaccinated or unknown vaccination status individuals, posing a renewed threat to the disease elimination status declared in 2000. The rise in cases is attributed to global increases in measles incidence, vaccine skepticism, and undervaccinated communities.

Promising Chlamydia Vaccine Trial Results

A promising chlamydia vaccine has shown positive results in an early-stage clinical trial, offering hope for prevention of the common STI.

Bird Flu Outbreak in U.S. Dairy Cattle

The U.S. Department of Agriculture confirms cows in multiple states have tested positive for bird flu, with a person in Texas also testing positive after contact with infected dairy cattle. The risk of human-to-human transmission is low, and health officials are closely monitoring the situation.

Indictment of Former Brazilian President Jair Bolsonaro

Former President Jair Bolsonaro of Brazil has been indicted on charges of conspiracy and falsifying vaccine data to travel to the US. If charges are filed, he may face up to 12 years in prison. The indictment is part of ongoing legal actions against Bolsonaro by the government of current President Luiz Inácio Lula da Silva.

Global Cholera Vaccine Shortage in 2024

The global stockpile of cholera vaccines is empty, leading to a shortage during a resurgence of cholera outbreaks in 2024. Demand for vaccines has outstripped supply, with 17 countries reporting cases and over 700,000 cases recorded. Efforts are being made to stretch the current vaccine supply and ramp up production, but challenges persist in replenishing the stockpile.

Cholera Vaccine Shortage

Global cholera vaccine stockpile is empty during outbreaks worldwide, WHO recommends halving vaccine dose to conserve supply.

Sinovac Vaccine Controversy in China

Almost 3,000 people in China claim to have suffered illnesses from the Sinovac coronavirus vaccine and are asking Chinese Communist Party officials to take responsibility. The victims face obstacles in speaking on the issue, with some experiencing retaliation for sharing their experiences. An expert believes the claims of injury are plausible, citing previous pharmaceutical scandals in China. The government has dismissed all claims of injury as 'irresponsible.'

Measles Outbreaks and Vaccine Immunity

The article discusses how measles outbreaks in the U.S. could be related to the waning immunity of individuals who were vaccinated for measles in the 1970s or '80s. Health experts recommend checking immunity status and getting a booster shot if necessary.

CDC Recommends Older Adults Get Another COVID-19 Shot

CDC recommends older U.S. adults get another COVID-19 shot, even if they received a booster in the fall, to provide added protection against the virus. The updated vaccine became available in September and is advised for individuals aged 65 and older.

Advancements in Cancer Research: Personalized Cancer Vaccines

Dr. Catherine Wu, an oncologist, has made significant contributions to cancer research through the development of personalized cancer vaccines tailored to the genetic makeup of individual tumors. Her work has shown promising results in early-stage trials and has the potential to be applicable to many forms of cancer.